propecia x finasterida

Information is Power!

Browsing Category 'Blood'

Chicago day

I am flying-off to Illinios today to cover the American Society of Clinical Oncology (ASCO) meetings in Chicago.  Here is a summary of some of the exciting cancer therapy related news we can expect to learn about there this weekend:

Continue reading...

I mentioned my impending stem cell transplant procedure a week or so ago.  I would, once again, like to apologize for not getting our news updates out to you lately. 

Continue reading...

This is an interesting article I found on OncologySTAT a while back:

Continue reading...

I thought it would be interesting to take a look at cancer research from an Asian perspective.  Here is a an article from the Website of a major newspaper from India, AndhraNews.net:

Continue reading...

OncologySTAT.com featured this Pink Sheet Daily article a few weeks ago.  The fact there are several good, front-line chemo drugs for use against chronic myeloid leukemia is good news, but not the story here.  This is a business story–a battle between drugs and drug companies.  Read the first part of the article and see what you think:
Bristol’s Once-daily Sprycel Faces Off Against Novartis’ Tasigna After Clearance in First-line Leukemia

The Pink Sheet Daily. 2010 Oct 28, E Hayes

Continue reading...

Millennium, a division of the Takeda Oncology Company in Japan, is a leading biopharmaceutical company based in Cambridge, Massachuesets. Millenium markets VELCADE, a proteasome inhibitor which is primarily used in multiple myeloma patients.

Continue reading...

We can thank Biosciencetechnology.com for this report about continuing genetic research which may help treat some non-Hodgkin’s lymphoma patients:

Continue reading...

Here is some leukemia/lymphoma news.  The first is from sifiNews.  Site name doesn’t fill you with confidence, does it?

Continue reading...

The Cancer Network’s Chronic Myeloid Leukemia Resource Center offers a number of helpful links and updates about the latest treatment advances and therapy options.

Continue reading...

Here is an exerpt from an article I saved last month, featuring more important work to help minority patients (and the rest of us!) by expanding collections of cord blood for those who need stem cell transplants:

Continue reading...

Here is a noteworthy article we found on Caring4Cancer.com today. This is an important trend, because it doesn’t only affect lymphoma patients. Lower dosing is a fortunate trend for patients fighting a number of different cancers:

Continue reading...

Cancer Research UK recently said that people diagnosed with non-Hodgkin’s lymphoma, bowel, breast and ovarian cancer – cancers that are notoriously difficult to treat and sometimes end in death – are now surviving in numbers that double previous figures.

Continue reading...